Skip to Content

3,027 Results Found

  • Review
  • Open Access
5,601 Views
21 Pages

CD20-Negative Large B-Cell Lymphomas: The Diagnostic Challenge of Tumors with Downregulation of Mature B-Cell Marker Expression

  • Magda Zanelli,
  • Maurizio Zizzo,
  • Francesca Sanguedolce,
  • Stefano Ricci and ,
  • Andrea Palicelli,
  • Alessandra Bisagni,
  • Valentina Fragliasso,
  • Giuseppe Broggi,
  • Serena Salzano and
  • Stefano Ascani
  • + 17 authors+ 12 authors

14 August 2025

CD20-negative aggressive B-cell lymphomas are a rare and heterogeneous group of lymphomas representing a diagnostic challenge for pathologists and a therapeutic issue for clinicians, because the outcome of these patients is poor with the current ther...

(This article belongs to the Section Molecular Oncology)
  • Review
  • Open Access
19 Citations
5,003 Views
11 Pages

A New Face of Fibrin-Associated Large B-Cell Lymphoma: Epstein–Barr Virus-Positive Breast Implant-Associated Diffuse Large B-Cell Lymphoma

  • Jose Manuel Martin de Bustamante,
  • Ana Mendoza,
  • Samuel López-Muñoz,
  • Eugenia García-Fernández and ,
  • Pilar Gómez-Prieto and
  • Victor Jiménez-Yuste
  • + 1 author+ 0 author

23 May 2023

Recently, there have been reports of what could be a new lymphoproliferative entity: breast implant-associated Epstein–Barr virus positive (EBV+) diffuse large B-cell lymphoma (EBV+ BIA-DLBCL). The new World Health Organization classification h...

(This article belongs to the Section Hematology)
  • Review
  • Open Access
3 Citations
8,827 Views
12 Pages

Primary Cutaneous B-Cell Lymphomas with Large Cell Morphology: A Practical Review

  • Andrea Ronchi,
  • Paola Vitiello,
  • Giuseppe D’Abbronzo,
  • Stefano Caccavale and ,
  • Giuseppe Argenziano,
  • Antonello Sica,
  • Roberto Alfano,
  • Giovanni Savarese,
  • Massimiliano Berretta and
  • Renato Franco
  • + 6 authors+ 1 author

Most primary cutaneous lymphomas consist of T-cell lymphomas or small cell lymphomas; however, the skin may also be affected by lymphomas with large cell morphology, as a primary or secondary localization. A minority of cases consist of primary cutan...

(This article belongs to the Special Issue Latest Review Papers in Molecular Immunology 2023)
  • Article
  • Open Access
3 Citations
3,097 Views
16 Pages

The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa

  • Stine Dahl Vest,
  • Patrick Rene Gerhard Eriksen,
  • Fleur A. de Groot,
  • Ruben A. L. de Groen and ,
  • Anne H. R. Kleij,
  • Marina Knudsen Kirkegaard,
  • Peter Kamper,
  • Peter Kristian Rasmussen,
  • Christian von Buchwald and
  • Steffen Heegaard
  • + 8 authors+ 3 authors

To provide insights into targetable oncogenic pathways, this retrospective cohort study investigated the genetic profile of 26 patients with diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS), and two patients with high-grade B-cell l...

(This article belongs to the Special Issue Advances in Molecular Understanding of Ocular Adnexal Disease)
  • Article
  • Open Access
3 Citations
4,186 Views
12 Pages

Development of New Diffuse Large B Cell Lymphoma Mouse Models

  • Syed Hassan Mehdi,
  • Ying-Zhi Xu,
  • Leonard D. Shultz,
  • Eunkyung Kim and ,
  • Yong Gu Lee,
  • Samantha Kendrick and
  • Donghoon Yoon
  • + 2 authors+ 0 author

29 August 2024

Diffuse large B cell lymphoma (DLBCL) is the most diagnosed, aggressive non-Hodgkin lymphoma, with ~40% of patients experiencing refractory or relapsed disease. Given the low response rates to current therapy, alternative treatment strategies are nec...

(This article belongs to the Section Methods and Technologies Development)
  • Review
  • Open Access
21 Citations
6,396 Views
24 Pages

Molecular Update and Evolving Classification of Large B-Cell Lymphoma

  • Arantza Onaindia,
  • Nancy Santiago-Quispe,
  • Erika Iglesias-Martinez and
  • Cristina Romero-Abrio

3 July 2021

Diffuse large B-cell lymphomas (DLBCLs) are aggressive B-cell neoplasms with considerable clinical, biologic, and pathologic diversity. The application of high throughput technologies to the study of lymphomas has yielded abundant molecular data lead...

(This article belongs to the Special Issue Molecular Advances in Diffuse Large B-Cell Lymphoma)
  • Case Report
  • Open Access
7 Citations
5,272 Views
10 Pages

Fluid Overload-Associated Large B-Cell Lymphoma: A Case Report and Review of Literature

  • Hisham F. Bahmad,
  • Aaron S. Gomez,
  • Arunima Deb,
  • Fernando Martin Safdie and
  • Vathany Sriganeshan

Fluid overload-associated large B-cell lymphoma (FO-LBCL) is a new entity described in the fifth edition of the World Health Organization (WHO) Classification of Hematolymphoid Tumors (WHO-HAEM5). It refers to malignant lymphoma present with symptoms...

  • Case Report
  • Open Access
8 Citations
1,364 Views
4 Pages

A Rare Case Report of Large B Cell Lymphoma in Adult Presentation as Intussusception

  • Amol N. Wagh,
  • Balamurugan Ganesan,
  • Hemant M. Jawale,
  • Rahul A. Mishra and
  • Rajeshwari Bhatt

16 October 2020

Adult intussusception represents 5% of all intussusceptions. Primary gastro-intestinal lymphoma comprises 1%-4% of all gastro-intestinal malignancies 90% of them are B-cell non-Hodgkin’s lymphoma (NHL). Most common NHL is diffuse large B-cell lymphom...

  • Article
  • Open Access
16 Citations
5,439 Views
15 Pages

Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas

  • Marie Donzel,
  • Florian Pesce,
  • Alexis Trecourt,
  • Razika Groussel and ,
  • Emmanuel Bachy,
  • Hervé Ghesquières,
  • Juliette Fontaine,
  • Nazim Benzerdjeb,
  • Claire Mauduit and
  • Alexandra Traverse-Glehen
  • + 5 authors+ 0 author

6 October 2023

Since the description of primary mediastinal large B-cell lymphoma (PMBL) as a distinct entity from diffuse large B-cell lymphomas (DLBCL), numerous studies have made it possible to improve their definition. Despite this, this differential diagnosis...

  • Article
  • Open Access
11 Citations
5,476 Views
17 Pages

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type

  • Valdemar Priebe,
  • Giulio Sartori,
  • Sara Napoli,
  • Elaine Yee Lin Chung and ,
  • Luciano Cascione,
  • Ivo Kwee,
  • Alberto Jesus Arribas,
  • Afua Adjeiwaa Mensah,
  • Andrea Rinaldi and
  • Francesco Bertoni
  • + 11 authors+ 6 authors

15 July 2020

Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B cell (GCB) DLBCL and activated-like B cell (ABC) DLBCL, based on transcriptome expressi...

(This article belongs to the Special Issue B Cell Malignancies (including B Cell Lymphoma, Multiple Myeloma and B-CLL))
  • Review
  • Open Access
3 Citations
11,419 Views
24 Pages

Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy

  • Laura Tomas-Roca,
  • Marta Rodriguez,
  • Ruth Alonso-Alonso,
  • Socorro M. Rodriguez-Pinilla and
  • Miguel Angel Piris

14 May 2021

Diffuse large B-cell lymphomas (DLBCL)s, the most common type of Non-Hodgkin’s Lymphoma, constitute a heterogeneous group of disorders including different disease sites, strikingly diverse molecular features and a profound variability in the clinical...

  • Review
  • Open Access
35 Citations
10,754 Views
19 Pages

20 November 2021

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease. B-cell receptor (BCR) pathway is essential for malignant B-cell growth, survival, and proliferation. Various immune cells, including T-cells and macrophages in the tumor microenvironme...

(This article belongs to the Special Issue Immune Therapies for Hematologic Malignancies)
  • Review
  • Open Access
14 Citations
4,790 Views
20 Pages

The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma

  • Jianbo Wu,
  • Fuqing Meng,
  • Danyang Ran,
  • Yalong Song and ,
  • Yunkun Dang,
  • Fan Lai,
  • Longyan Yang,
  • Mi Deng,
  • Yuqin Song and
  • Jun Zhu
  • + 5 authors+ 0 author

Cells utilize different metabolic processes to maintain their growth and differentiation. Tumor cells have made some metabolic changes to protect themselves from malnutrition. These metabolic alterations affect the tumor microenvironment and macroenv...

(This article belongs to the Special Issue Nutrition and Metabolism in Human Diseases)
  • Article
  • Open Access
225 Views
15 Pages

14 October 2026

Background: Programmed death-ligand 1 (PD-L1) contributes to immune escape and is a therapeutically relevant target in aggressive B-cell lymphomas. However, its distribution and clinicopathologic significance across primary mediastinal aggressive lar...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
5 Citations
2,075 Views
19 Pages

Simulating Interclonal Interactions in Diffuse Large B-Cell Lymphoma

  • Siddarth R. Ganesh,
  • Charles M. Roth and
  • Biju Parekkadan

Diffuse large B-cell lymphoma (DLBCL) is one of the most common types of cancers, accounting for 37% of B-cell tumor cases globally. DLBCL is known to be a heterogeneous disease, resulting in variable clinical presentations and the development of dru...

  • Case Report
  • Open Access
2 Citations
1,264 Views
3 Pages

14 June 2019

Secondary acute lymphoblastic leukemia (ALL) is a rare disease that has not been well characterized compared with secondary myelodysplastic syndrome or secondary acute myeloid leukemia. We present a report of two patients who developed ALL following...

  • Article
  • Open Access
8 Citations
4,144 Views
12 Pages

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas

  • Ivonne Vazquez,
  • Natalia Papaleo,
  • Eugenia Garcia,
  • Marta Salido and ,
  • Antonio Salar,
  • Silvia Hernandez,
  • Xavier Calvo and
  • Luis Colomo
  • + 3 authors+ 0 author

5 April 2020

MYC rearrangements usually confer aggressive biological behavior to large B-cell lymphomas. In this study, we aimed to evaluate the relevance of LMO2 detection to the clinical approach to these tumors. First, the ability of LMO2 loss of expression to...

(This article belongs to the Special Issue Recent Advances in the Pathogenesis of B Cell Malignancies)
  • Review
  • Open Access
20 Citations
5,925 Views
22 Pages

30 April 2021

Diffuse large B cell lymphoma (DLBCL) is curable with chemoimmunotherapy in ~65% of patients. One of the hallmarks of the pathogenesis and resistance to therapy in DLBCL is inhibition of apoptosis, which allows malignant cells to survive and acquire...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
53 Citations
9,465 Views
15 Pages

Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice

  • Carlo Visco,
  • Ilaria Tanasi,
  • Francesca Maria Quaglia,
  • Isacco Ferrarini and ,
  • Costanza Fraenza and
  • Mauro Krampera
  • + 1 author+ 0 author

10 October 2020

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin’s lymphoma in adults. Despite the recognition of transcriptional subtypes with distinct functional characteristics, patient outcomes have not been substantially altered since...

(This article belongs to the Special Issue Hematologic Malignancy)
  • Case Report
  • Open Access
1 Citations
5,260 Views
8 Pages

Gastro-Splenic Fistula Related to Large B Cell Lymphoma

  • Diana Triantafyllopoulou,
  • Ioannis Gkikas,
  • Jagdish Adiyodi,
  • Iain Crossingham and ,
  • Shofiq Al-Islam,
  • Muhammad Shahbaz Alam,
  • Neil Sahasrabudhe,
  • Ambareen Kausar,
  • Ali Bin Ayub and
  • Reuben Tooze
  • + 9 authors+ 4 authors

17 June 2020

We report a case of spontaneous gastrosplenic fistula in a 57 year old female who presented to the emergency department with abdominal pain and weight loss. From the physical examination, she had a palpable abdominal mass. A CT scan was performed and...

  • Review
  • Open Access
18 Citations
13,393 Views
18 Pages

Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma

  • Aisling M. Ross,
  • Ciara I. Leahy,
  • Fiona Neylon,
  • Jana Steigerova and ,
  • Patrik Flodr,
  • Martina Navratilova,
  • Helena Urbankova,
  • Katerina Vrzalikova,
  • Lucia Mundo and
  • Paul G. Murray
  • + 8 authors+ 3 authors

14 February 2023

Epstein–Barr virus (EBV), defined as a group I carcinogen by the World Health Organization (WHO), is present in the tumour cells of patients with different forms of B-cell lymphoma, including Burkitt lymphoma, Hodgkin lymphoma, post-transplant lympho...

(This article belongs to the Section Microbiology)
  • Review
  • Open Access
10 Citations
9,983 Views
19 Pages

In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies

  • Matylda Kubacz,
  • Aleksandra Kusowska,
  • Magdalena Winiarska and
  • Małgorzata Bobrowicz

30 December 2022

Despite the high incidence of diffuse large B-cell lymphoma (DLBCL), its management constitutes an ongoing challenge. The most common DLBCL variants include activated B-cell (ABC) and germinal center B-cell-like (GCB) subtypes including DLBCL with MY...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Review
  • Open Access
25 Citations
9,417 Views
28 Pages

Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas

  • Francesco D’Alò,
  • Silvia Bellesi,
  • Elena Maiolo,
  • Eleonora Alma and ,
  • Flaminia Bellisario,
  • Rosalia Malafronte,
  • Marcello Viscovo,
  • Fabrizia Campana and
  • Stefan Hohaus
  • + 4 authors+ 0 author

17 June 2024

Since the introduction of rituximab in the late 1990s, significant progress has been made in advancing targeted therapies for B cell lymphomas, improving patients’ chance of being cured and clinicians’ therapeutic armamentarium. A better...

(This article belongs to the Section Methods and Technologies Development)
  • Review
  • Open Access
1,440 Views
23 Pages

Diffuse Large B-Cell Lymphoma: From Molecular Stratification to Precision Immunotherapy

  • Akbar Pasha,
  • Aayushi Velingkar,
  • Ramita Sharma,
  • Priyanka Tiwari and ,
  • Manasi Mundada,
  • Rohan Tewani,
  • Dylan T. Jochum,
  • Rashid Mir,
  • Faiq Ahmed and
  • Waseem G. Lone
  • + 11 authors+ 6 authors

30 June 2026

Diffuse large B-cell lymphoma (DLBCL) is a biologically heterogeneous mature B-cell neoplasm whose classification, prognosis, and therapy have been reshaped by advances in genomic, transcriptomic, epigenomic, single-cell, and spatial profiling techno...

(This article belongs to the Special Issue Novel Immunotherapies for Diffuse Large B-Cell Lymphoma)
  • Case Report
  • Open Access
1 Citations
2,102 Views
10 Pages

Fluid Overload-Associated Large B-Cell Lymphoma Presenting as Isolated Pleural Effusion

  • Kevin Leeper,
  • Lauren Borecky,
  • Mojtaba Akhtari and
  • Jun Wang

Primary effusion-based lymphomas are uncommon and may pose significant diagnostic challenges. Fluid overload-associated large B-cell lymphoma is a recently recognized entity in the 5th edition of the World Health Organization Classification of Hemato...

  • Review
  • Open Access
7 Citations
12,070 Views
9 Pages

21 July 2022

The definitions of follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are evolving in the era of personalized medicine. Early stages of the evolution of FL have been recognized. Two histological manifestations of early lesions are in...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Article
  • Open Access
9 Citations
3,933 Views
22 Pages

High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients

  • Dario Marino,
  • Marco Pizzi,
  • Iuliia Kotova,
  • Ronny Schmidt and ,
  • Christoph Schröder,
  • Vincenza Guzzardo,
  • Ilaria Talli,
  • Edoardo Peroni,
  • Silvia Finotto and
  • Erich Piovan
  • + 10 authors+ 5 authors

11 January 2022

The identification of prognostic factors for aggressive B-cell lymphomas still represents an unmet clinical need. We used forward phase protein arrays (FFPA) to identify proteins associated with overall survival (OS) from diagnostic formalin-fixed pa...

(This article belongs to the Section Cancer Pathophysiology)
  • Review
  • Open Access
33 Citations
6,788 Views
17 Pages

Diffuse Large B-Cell Lymphoma in the HIV Setting

  • Maria Huguet,
  • José-Tomás Navarro,
  • José Moltó,
  • Josep-Maria Ribera and
  • Gustavo Tapia

15 June 2023

Despite the widespread use of combined antiretroviral therapy (cART) and the subsequent decrease in AIDS-defining cancers, HIV-related lymphomas remain a leading cause of morbidity and mortality in people with HIV (PWH). Diffuse large B-cell lymphoma...

(This article belongs to the Special Issue Advances in the Diagnosis, Prognosis and Treatment of Diffuse Large B-cell Lymphoma)
  • Review
  • Open Access
5 Citations
7,663 Views
12 Pages

5 March 2025

Outcomes in older, unfit, and frail patients with diffuse large B-cell lymphoma (DLBCL) are inferior compared to younger and fit patients. Despite tremendous progress in the treatment landscape of DLBCL, few clinical trials have focused specifically...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
57 Citations
11,811 Views
34 Pages

Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Concepts

  • Katrin S. Kurz,
  • Michaela Ott,
  • Sabrina Kalmbach,
  • Sophia Steinlein and ,
  • Claudia Kalla,
  • Heike Horn,
  • German Ott and
  • Annette M. Staiger
  • + 3 authors+ 0 author

13 April 2023

The family/class of the large B-cell lymphomas (LBCL) in the 5th edition of the World Health Organization (WHO) classification of haematolymphoid tumors (WHO-HAEM5) features only a few major changes as compared to the 4th edition. In most entities, t...

(This article belongs to the Special Issue Advances in the Diagnosis, Prognosis and Treatment of Diffuse Large B-cell Lymphoma)
  • Review
  • Open Access
35 Citations
8,880 Views
12 Pages

Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  • Leonard Jeff Harris,
  • Kruti Patel and
  • Michael Martin

13 November 2020

The most common type of non-Hodgkin lymphoma in adults is diffuse large B-cell (DLBCL). There is a historical unmet need for more effective therapies in the 2nd and 3rd line setting. Emerging immunochemotherapies have shown activity in small studies...

(This article belongs to the Special Issue Novel Approaches to Hematologic Malignancies by Immunotherapy)
  • Article
  • Open Access
3 Citations
4,775 Views
15 Pages

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma

  • Jessica Rodrigues Plaça,
  • Arjan Diepstra,
  • Tjitske Los,
  • Matías Mendeville and ,
  • Annika Seitz,
  • Pieternella J. Lugtenburg,
  • Josée Zijlstra,
  • King Lam,
  • Wilson Araújo da Silva and
  • Marcel Nijland
  • + 8 authors+ 3 authors

5 March 2022

Multiple gene expression profiles have been identified in diffuse large B-cell lymphoma (DLBCL). Besides the cell of origin (COO) classifier, no signatures have been reproduced in independent studies or evaluated for capturing distinct aspects of DLB...

(This article belongs to the Special Issue Molecular Characterization of Hematological Tumors)
  • Article
  • Open Access
15 Citations
3,809 Views
9 Pages

Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma

  • Alfredo Rivas-Delgado,
  • Ferran Nadeu,
  • Marcio Andrade-Campos,
  • Cristina López and ,
  • Anna Enjuanes,
  • Pablo Mozas,
  • Gerard Frigola,
  • Luis Colomo,
  • Blanca Sanchez-Gonzalez and
  • Beatriz Bellosillo
  • + 11 authors+ 6 authors

High-throughput sequencing of cell-free DNA (cfDNA) has emerged as a promising noninvasive approach in lymphomas, being particularly useful when a biopsy specimen is not available for molecular analysis, as it frequently occurs in primary mediastinal...

(This article belongs to the Special Issue Cell-Free Nucleic Acids—New Insights into Physico-Chemical Properties, Analytical Considerations, and Clinical Applications)
  • Case Report
  • Open Access
3 Citations
4,024 Views
7 Pages

Use of Liquid-based Cytology and Cell Block Combined Technique for an Accurate Diagnosis of Oral Diffuse Large B Cell Lymphoma: A Case Report

  • Aya Yoshino,
  • Shintaro Ishida,
  • Shinsuke Nakamura,
  • Ryosuke Kita and ,
  • Mika Seto,
  • Shinji Matsumoto,
  • Morishige Takeshita and
  • Seiji Kondo
  • + 3 authors+ 0 author

14 October 2020

Primary oral diffuse large B cell lymphoma (DLBCL) is rare and the differential diagnosis is difficult due to its low incidence and nonspecific symptoms, which resemble those of common oral diseases in the initial clinical setting. We aimed to discus...

(This article belongs to the Special Issue Biomarkers of Oral Cancer)
  • Feature Paper
  • Review
  • Open Access
14 Citations
8,733 Views
22 Pages

An Overview on Diffuse Large B-Cell Lymphoma Models: Towards a Functional Genomics Approach

  • Natalia Yanguas-Casás,
  • Lucía Pedrosa,
  • Ismael Fernández-Miranda and
  • Margarita Sánchez-Beato

9 June 2021

Lymphoma research is a paradigm of the integration of basic and clinical research within the fields of diagnosis and therapy. Clinical, phenotypic, and genetic data are currently used to predict which patients could benefit from standard treatment. H...

(This article belongs to the Special Issue Molecular Advances in Diffuse Large B-Cell Lymphoma)
  • Article
  • Open Access
24 Citations
6,448 Views
24 Pages

Proteomic Landscape of Extracellular Vesicles for Diffuse Large B-Cell Lymphoma Subtyping

  • Ana Sofia Carvalho,
  • Henrique Baeta,
  • Andreia F. A. Henriques,
  • Mostafa Ejtehadifar and ,
  • Erin M. Tranfield,
  • Ana Laura Sousa,
  • Ana Farinho,
  • Bruno Costa Silva,
  • José Cabeçadas and
  • Rune Matthiesen
  • + 8 authors+ 3 authors

12 October 2021

The role of extracellular vesicles (EVs) proteome in diffuse large B-cell lymphoma (DLBCL) pathology, subclassification, and patient screening is unexplored. We analyzed by state-of-the-art mass spectrometry the whole cell and secreted extracellular...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
3 Citations
5,226 Views
15 Pages

The Clinical and Biological Effects of PD-1 Expression on Tumor Cells in Diffuse Large B-Cell Lymphoma

  • Ichiro Hanamura,
  • Susumu Suzuki,
  • Akinobu Ota,
  • Satsuki Murakami and ,
  • Akira Satou,
  • Taishi Takahara,
  • Sivasundaram Karnan,
  • Vu Quang Lam,
  • Ayano Nakamura and
  • Akiyoshi Takami
  • + 12 authors+ 7 authors

7 June 2021

The clinical and biological significance of programmed death-1 (PD-1) expression by B-lymphoma cells is largely unknown. Here, using multicolor immunofluorescent staining (MC-IF), we investigated PD-1 and PD-L1 expression in PAX5+ (B-lymphoma), CD68+...

(This article belongs to the Section Lymphomas)
  • Article
  • Open Access
1,446 Views
14 Pages

Overexpression of CDCA2 in Diffuse Large B-Cell Lymphoma Promotes Cell Proliferation and Bortezomib Sensitivity

  • Hanne Due,
  • Asta Brogaard,
  • Issa Ismail Issa,
  • Maja Zimmer Jakobsen and ,
  • Cathrine Sylvester,
  • Anne Krogh Nøhr,
  • Louiza Bohn Thomsen,
  • Martin Kristian Thomsen,
  • Rasmus Froberg Brøndum and
  • Karen Dybkær
  • + 5 authors+ 0 author

Numerous clinical trials have attempted to improve first-line R-CHOP treatment of diffuse large B-cell lymphoma (DLBCL) through the addition or substitution of drugs. The REMoDL-B trial, testing the addition of bortezomib (RB-CHOP), revealed that ABC...

(This article belongs to the Section Molecular Oncology)
  • Interesting Images
  • Open Access
1 Citations
1,693 Views
5 Pages

Postmortem Detection of “Clinically Undiagnosed” Diffuse Large B-Cell Lymphoma: Gross and Microscopic Findings

  • Vincenzo Cianci,
  • Daniela Sapienza,
  • Giovanni Bartoloni,
  • Alessio Cianci and ,
  • Annalisa Cracò,
  • Fausto Omero,
  • Patrizia Gualniera,
  • Alessio Asmundo and
  • Cristina Mondello
  • + 4 authors+ 0 author

29 August 2024

Diffuse large B-cell lymphoma is considered the most found non-Hodgkin lymphoma in adults. Diffuse large B-cell lymphoma, which also occurs in sporadic forms, is associated with some pathological conditions, including human immunodeficiency virus inf...

(This article belongs to the Special Issue Updates on Forensic Pathology)
  • Review
  • Open Access
12 Citations
4,758 Views
13 Pages

The Evolving Role of Bispecific Antibodies in Diffuse Large B-Cell Lymphoma

  • Khalil Saleh,
  • Rita Khoury,
  • Nadine Khalife,
  • Claude Chahine and ,
  • Rebecca Ibrahim,
  • Zamzam Tikriti and
  • Axel Le Cesne
  • + 2 authors+ 0 author

21 June 2024

The advent of targeted therapies such as monoclonal antibodies, adoptive T-cell therapies, and antibody–drug conjugates (ADCs) dramatically changed the treatment landscape of diffuse large B-cell lymphoma (DLBCL) over the last two decades. Ritu...

(This article belongs to the Section Personalized Therapy and Drug Delivery)
  • Review
  • Open Access
3 Citations
3,588 Views
16 Pages

Updates on Chimeric Antigen Receptor T-Cells in Large B-Cell Lymphoma

  • Khalil Saleh,
  • Nadine Khalife,
  • Ahmadreza Arbab,
  • Rita Khoury and ,
  • Claude Chahine,
  • Rebecca Ibrahim,
  • Zamzam Tikriti,
  • Nohad Masri,
  • Mohamad Hachem and
  • Axel Le Cesne
  • + 5 authors+ 0 author

11 December 2024

CD19-targeting chimeric antigen receptor (CAR) T-cells have changed the treatment paradigm of patients with large B-cell lymphoma (LBCL). Three CAR T-cells were approved by the Food and Drug Administration (FDA) for patients with relapsed and/or refr...

(This article belongs to the Special Issue Advances in CAR-T Cell Therapy)
  • Case Report
  • Open Access
5 Citations
3,056 Views
7 Pages

5 October 2023

Background: Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin’s lymphoma, often presents diagnostic challenges due to its diverse clinical presentation. We present a case of DLBCL that was initially misdiagnosed as a...

(This article belongs to the Section Oncology)
  • Review
  • Open Access
41 Citations
8,488 Views
15 Pages

31 May 2021

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin’s lymphoma (NHL) in adults. Epstein–Barr virus (EBV) positive DLBCL of the elderly was defined by the World Health Organization (WHO) in 2008, it was restricted only to patients old...

(This article belongs to the Special Issue Molecular Advances in Diffuse Large B-Cell Lymphoma)
  • Review
  • Open Access
3 Citations
3,716 Views
16 Pages

Current Issues and Future Perspectives of Targeted Therapies in Primary Mediastinal Large B-Cell Lymphoma

  • Athanasios Liaskas,
  • Maria N. Dimopoulou,
  • Alexia Piperidou,
  • Maria K. Angelopoulou and
  • Theodoros P. Vassilakopoulos

11 February 2025

Primary mediastinal large B-cell lymphoma (PMLBCL) is a rare, aggressive B-cell lymphoma, sharing common features with diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL). PMLBCL is usually cured with single-hit immunochemotherapy in the...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
23 Citations
4,400 Views
25 Pages

Extracellular Vesicles in Diffuse Large B Cell Lymphoma: Characterization and Diagnostic Potential

  • Rune Matthiesen,
  • Paula Gameiro,
  • Andreia Henriques,
  • Cristian Bodo and ,
  • Maria Carolina Strano Moraes,
  • Bruno Costa-Silva,
  • José Cabeçadas,
  • Maria Gomes da Silva,
  • Hans Christian Beck and
  • Ana Sofia Carvalho
  • + 5 authors+ 0 author

1 November 2022

Diffuse large B cell lymphoma (DLBCL) is an aggressive B cell lymphoma characterized by a heterogeneous behavior and in need of more accurate biological characterization monitoring and prognostic tools. Extracellular vesicles are secreted by all cell...

(This article belongs to the Special Issue The Role of Exosomes in Cancer Diagnosis and Therapy)
  • Article
  • Open Access
22 Citations
5,387 Views
14 Pages

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma

  • Marcel Nijland,
  • Annika Seitz,
  • Martijn Terpstra,
  • Gustaaf W. Van Imhoff and ,
  • Philip M Kluin,
  • Tom Van Meerten,
  • Çiğdem Atayar,
  • Léon C. Van Kempen,
  • Arjan Diepstra and
  • Anke Van den Berg
  • + 6 authors+ 1 author

20 November 2018

Current genomic models in diffuse large B-cell lymphoma (DLBCL) are based on single tumor biopsies, which might underestimate heterogeneity. Data on mutational evolution largely remains unknown. An exploratory study using whole exome sequencing on pa...

  • Article
  • Open Access
1 Citations
2,028 Views
11 Pages

The aim of this study is to investigate whether there is a cut-off value for PD-L1 expression in large B-cell lymphomas that predicts prognosis, and to clarify the relationship between PD-L1 expression and histopathological as well as clinical parame...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Case Report
  • Open Access
1 Citations
5,658 Views
7 Pages

Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Presenting with Distributive Shock

  • Nisha Hariharan,
  • Alisha Kabadi,
  • Michelle Don,
  • Mazen Odish and
  • Benjamin Heyman

16 November 2023

Diffuse large B-cell lymphoma (DLBCL) and angioimmunoblastic T-cell lymphoma (AITL) are two subtypes of non-Hodgkin lymphoma (NHL). The simultaneous occurrence of DLBCL and AITL in a composite lymphoma is very rare, and there are no established treat...

  • Review
  • Open Access
29 Citations
9,160 Views
18 Pages

11 August 2021

Primary testicular lymphoma is a rare lymphoma entity, yet it is the most common testicular malignancy among elderly men. The majority of the cases represent non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma (DLBCL) with aggress...

(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
  • Brief Report
  • Open Access
4 Citations
3,222 Views
10 Pages

Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma

  • Emilio Bellitti,
  • Pierluigi Masciopinto,
  • Pellegrino Musto,
  • Elena Arcuti and ,
  • Luca Mastracci,
  • Giuseppina Opinto,
  • Sabino Ciavarella,
  • Attilio Guarini,
  • Gerardo Cazzato and
  • Giuseppe Ingravallo
  • + 8 authors+ 3 authors

25 August 2022

The metachronic onset of diffuse large B-cell lymphoma (DLBCL) after classic Hodgkin lymphoma (cHL) is a rare event affecting patients’ outcomes. However, although several studies have investigated the prognostic role of this event, little is k...

(This article belongs to the Special Issue Haematological Neoplasms: Diagnosis and Management)

of 61